Yesehak Abraham: Enoxaparin Is The Quiet Hero in Clot Prevention
Yesehak Abraham, Social Media Manger at Sheromeda Gebya, Sales and Marketing Officer at Ze-el Pharmaceutical Import, shared a post on LinkedIn:
“Enoxaparin: The Quiet Hero in Blood Clot Prevention
Most people never think about blood clots… until they become a problem.
That’s where Enoxaparin steps in a small injection with a big clinical impact.
What it does :
It helps prevent dangerous clots by slowing down specific clotting factors (especially Factor Xa), keeping blood flow smooth and safe.
Where it’s commonly used:
- Post – surgery patients
- Bedridden or immobile patients
- Acute coronary syndromes
- DVT/PE prevention and treatment
Clinical reality:
Predictable. Effective. No routine monitoring in most cases.
But always respect renal function and bleeding risk.
‘Enoxaparin doesn’t dissolve clots… it just politely stops them from forming group chats in your bloodstream.’
Patient reminder:
- Small bruises can be normal
- Don’t massage injection sites
- Report unusual bleeding immediately
Final thought:
Sometimes the most powerful treatments are not dramatic – just precise, consistent, and quietly life – saving.”
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 14:03Blood Clots Can Happen to Anyone – NBCA
-
Apr 29, 2026, 14:03Tushar Pandey: The Spectrum of Bleeding Disorders
-
Apr 29, 2026, 14:00Advancing Rapid Prehospital Stroke Diagnosis Through StrokeCap Innovative Technology – ForTra
-
Apr 29, 2026, 13:52Bhaskar Tripathi: Heat Stroke Is a Silent Workplace Hazard We Can’t Ignore
-
Apr 29, 2026, 13:48Flora Peyvandi: Point-of-Care Testing for Rapid Detection of Factor VIII Inhibitors in Haemophilia A
-
Apr 29, 2026, 13:25Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age
-
Apr 29, 2026, 13:14Jan Sloves: Iliocaval Duplex Ultrasound as a Decision-Making Tool
-
Apr 29, 2026, 12:30Abdallah Othman: Thrombosis Forms a Clot, Narrowing the Vessel and Reducing Blood Flow
-
Apr 29, 2026, 07:12Matteo Foschi: Is There a Benefit to Switching DOACs After Breakthrough Stroke?